Evidence map›Paper›PMID 35967213›Full record

ArticleJTCVS techniques2022

Mitral valve surgery after failed transcatheter edge-to-edge repair.

Piotr Mazur, Arman Arghami, Clark Zheng, Mohamad Alkhouli, Hartzell V Schaff, Joseph Dearani, Richard C Daly, Kevin Greason, Juan A Crestanello

Abstract read
In one paragraph

Article in JTCVS techniques, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Piotr MazurDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Arman ArghamiDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Clark ZhengMayo Clinic Alix School of Medicine, Rochester, Minn.
Mohamad AlkhouliDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.
Hartzell V SchaffDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Joseph DearaniDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Richard C DalyDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Kevin GreasonDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Juan A CrestanelloDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Mitral valve operations for failed transcatheter edge-to-edge repair (TEER) are increasing. This study investigated the indications, surgical procedures, and outcomes after surgery for failed TEER. Methods: We analyzed records of patients who underwent mitral valve operations after TEER between January 2013 and September 2021. Patient characteristics, clip number and location, indications, timing, surgery type, and outcomes were evaluated. Results: A total of 41 patients (median age, 77 years; 14 women; median Society of Thoracic Surgeons predicted risk of mortality score, 9.4% [5.6%-12.6%]; and previous cardiac surgery in 21 patients) underwent mitral valve surgery at a median of 8 months (range, 4-16 months) after TEER. One clip was implanted in 24 patients and 2 or more in 17 patients. Indications for surgery were severe mitral regurgitation in 33, severe mitral stenosis in 1 patient, and both in 7 patients. Operations were performed via sternotomy in 37 patients and lateral thoracotomy in 4 patients. The mitral valve was replaced in all patients (bioprosthesis in 35 patients and a mechanical valve in 6 patients). Concomitant procedures were performed in 30 patients. Operative mortality was 5% (observed to expected ratio, 0.53) and did not differ for primary procedures versus reoperations. Echocardiographic follow-up demonstrated no or trivial mitral regurgitation in 34 patients, mild mitral regurgitation in 5 patients, and moderate perivalvular mitral regurgitation in 1 patient with severe mitral annular calcification. At a median follow-up of 1.5 years (interquartile range, 4.7 months-2.7 years), the actuarial survival was 79%. Conclusions: Mitral valve replacement can be performed safely after failed TEER with operative mortality lower than expected even in high-risk patients. Video Abstract:

Indexed as

ACC, American College of CardiologyCABG, coronary artery bypass graftingcardiac surgeryMitraClipmitral valvemitral valve replacementO/E, observed to expectedPROM, Predicted Risk of Operative MortalitySTS, Society of Thoracic SurgeonsTEER, transcatheter edge-to-edge repairtranscatheter edge-to-edge repairTVT, transcatheter valve therapy

Identifiers

PMID35967213
PMCPMC9366625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.